Stay updated on INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.

Latest updates to the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the usual study details with an error screen and a Home link. This prevents viewing essential trial information and attached documents.SummaryDifference20%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe current page revision has been updated to v3.6.6, replacing the previous v3.6.5 in the revision history. This appears to be a routine maintenance update and does not change the study content beyond the version label.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new deployment of the content. This update does not modify study details or other visible information.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, indicating a minor update to the study record page. This does not reflect changes to the study data or eligibility criteria.SummaryDifference0.0%

- Check90 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, indicating a small update to the page's version.SummaryDifference0.0%

- Check97 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a routine administrative update to the ClinicalTrials.gov entry. This update does not indicate changes to the study data or enrollment details.SummaryDifference0.0%

Stay in the know with updates to INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.